[{"Assets_0_Q1_USD":1886245000.0,"CommonStockSharesConverted_0_Q1_shares":105914000.0,"CommonStockSharesOutstanding_0_Q1_shares":84929000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":27871000.0,"NetIncomeLossConverted_1_Q1_USD":111856000.0,"StockholdersEquity_0_Q1_USD":107674000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":86705000.0,"StockholdersEquityConverted_0_Q1_USD":108055000.0,"EarningsPerShareBasic_1_Q1_USD":1.31,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":85427000.0,"EarningsPerShareDiluted_1_Q1_USD":1.29,"RevenuesConverted_1_Q1_USD":626336000.0,"Ticker":"IDXX","CIK":"874716","name":"IDEXX LABORATORIES INC \/DE","OfficialName":"IDEXX Laboratories Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"42180715521.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"SP500","filed":"20200430"}]